The clinical study will evaluate MRK's experimental antibody treatment in patients with diabetic macular edema, a major cause of vision loss.

Learn about the latest research linking insulin and metformin in diabetic foot ulcer exudates, paving the way for innovative treatment approaches

Relay Therapeutics, Inc., a clinical─stage precision medicine company transforming the drug discovery process by combining leading─edge...

Competitive: ICON Strategic Solutions: ICON plc is a world-leading healthcare intelligence and clinical research organisation. From molecule to...

Competitive: ICON Strategic Solutions: ICON plc is a world-leading healthcare intelligence and clinical research organisation. From molecule to...

Diabetes can affect a person’s gait, potentially leading to severe foot complications. A study presented at the European Society of Cardiology’s...

Competitive: ICON Plc: Study Start Up Associate, Clinical Site Activation - Poland, Croatia, Latvia ICON plc is a world-leading healthcare...

Dr. Scholl is a globally recognized leader in the field of ophthalmology and the coordinating principal investigator of the largest ever natural...

Dr. Scholl is a globally recognized leader in the field of ophthalmology and the coordinating principal investigator of the largest ever natural...

Competitive: Life Science People: Our client is a pioneering pharmaceutical company dedicated to transforming medicine through advanced drug delivery...